SG Blocks SGBX 深 沪
等待开盘 12-20 09:30:00 美东时间
2.38
-0.030
-1.24%
华盛通- 最 高4.50
- 今 开2.71
- 成交量 683.22万股
- 最 低 2.36
- 昨 收 2.41
- 总市值 2857.64万
- 52周最高 10.50
- 市盈率 静 --
- 换手率 56.90%
- 52周最低 0.122
- 委 比 26.95%
- 总股本 1200.69万
- 历史最高 139.98
- 量 比 9.08
- 振 幅 88.80%
- 历史最低 0.1005
- 每 手 1
- 风险率 2.22%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Safe & Green Holdings Closes Cash-And-Stock Acquisition of Giant Containers
Safe & Green Holdings Corp. (NASDAQ:SGBX) ("Safe & Green" or the "Company"), announced that it has successfully closed the acquisition of Giant Containers Inc. ("Giant Containers"), a leading manufacturer of
12-19 21:17
12 Industrials Stocks Moving In Friday's After-Market Session
Gainers Safe & Green Holdings (NASDAQ:SGBX) stock increased by 15.9% to $3...
11-29 05:05
12 Industrials Stocks Moving In Thursday's Intraday Session
Gainers Nuvve Holding (NASDAQ:NVVE) shares moved upwards by 206.3% to $0.48 du...
11-14 01:06
Why Cisco Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Shares of Cisco Systems, Inc. (NASDAQ:CSCO) rose sharply in pre-market trading ...
11-13 18:16
Safe and Green Holdings Corp. Engages ShareIntel to Investigate Unusual Trading Activity
Safe & Green Holdings Corp. has retained ShareIntel to investigate potential illegal trading activities, including naked short selling and market manipulation, affecting its stock. The company will use ShareIntel’s DRIL-Down™ analytics to identify irregularities and protect investor interests.
06-10 13:15
Sagimet Biosciences to Host Virtual KOL Event, “A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to Severe Acne” on June 16, 2025
Sagimet Biosciences will host a virtual KOL event on June 16, 2025, featuring Neal Bhatia, MD, to discuss positive results from a Phase 3 trial of denifanstat for moderate to severe acne vulgaris in China. Denifanstat, a daily oral FASN inhibitor, met all endpoints versus placebo and showed strong tolerability, highlighting FASN inhibition as a novel acne treatment. The company also initiated a Phase 1 trial for TVB-3567, its second FASN inhibitor targeting acne in the U.S.
06-09 11:00
Safe and Green Holdings Receives Court-Ordered Award of More Than $1.1 Million for Attorney’s Fees and Costs as Part of EDI Litigation
Safe & Green Holdings Corp. has received a court-ordered award of approximately $1.157 million for attorney’s fees and costs related to its litigation against EDI International, in addition to a $1.274 million jury verdict in its favor. The amounts remain subject to appeal.
06-04 12:30
Safe & Green Holdings Corp. Signs Letter of Intent to Acquire Giant Containers Inc.
Safe & Green Holdings has signed a non-binding LOI to acquire Giant Containers Inc., a modular infrastructure solutions leader. The deal includes Giant’s $6.8M project pipeline and its CEO Daniel Kroft joining Safe & Green as VP of Business Development. This acquisition aims to expand Safe & Green’s modular capabilities and aligns with its mission to deliver ESG-aligned infrastructure solutions.
06-02 12:30
Safe and Green Holdings Acquires 1,600 Acres of Oil Wells and Oil Leases
Safe & Green Holdings acquires Sherman Oil's assets, expanding its oil production holdings by 1,600 acres and 111 wells, with plans to boost output to over 75 barrels per day using its Olenox technology.
05-29 13:25
